Eli Lilly and Company has chosen the Lehigh Valley in Pennsylvania for its next manufacturing site in a $3.5 billion ...

Libris Innovations, the for-profit subsidiary of the Indiana Biosciences Research Institute (IBRI), has appointed Ramani ...

Merz Therapeutics has appointed Dan Staner as President, Region Europe, effective February 1, 2026. In this role, Staner will ...

Ardena has completed the process of divesting its active pharmaceutical ingredient (API) site in Södertälje, Sweden, to Nanologica AB.

In the evolving landscape of pharmaceutical development, modified release (MR) tablets have emerged as a cornerstone technology for improving therapeutic outcomes and patient compliance. Unlike ...

Expansions in the US and Europe are included in a €1.5 billion investment plan ...

Veeva Systems has announced Veeva eSource, a new Veeva SiteVault application designed to streamline the flow of clinical ...

Extractables and Leachables (E&L) issues are quietly derailing nearly one in five drug applications, as shown by hundreds of ...

Potency assays are central to proving a therapy activity and safety, yet for advanced therapies like cell and gene therapies ...

Vetter, a pharmaceutical service provider for the production of injectable drugs, has announced plans to build a new ...

AstraZeneca has announced a $15 billion investment in China through 2030 to expand medicines manufacturing and R&D.

Cell and gene therapies (CGTs) are revolutionizing treatment, but increasing regulatory scrutiny has led to a rise in costly ...